263 related articles for article (PubMed ID: 15963467)
1. Functional VEGF C-634G polymorphism is associated with development of diabetic macular edema and correlated with macular retinal thickness in type 2 diabetes.
Awata T; Kurihara S; Takata N; Neda T; Iizuka H; Ohkubo T; Osaki M; Watanabe M; Nakashima Y; Inukai K; Inoue I; Kawasaki I; Mori K; Yoneya S; Katayama S
Biochem Biophys Res Commun; 2005 Aug; 333(3):679-85. PubMed ID: 15963467
[TBL] [Abstract][Full Text] [Related]
2. Association between vascular endothelial growth factor gene polymorphisms and age-related macular degeneration in a Polish population.
Janik-Papis K; Zaras M; Krzyzanowska A; Wozniak K; Blasiak J; Szaflik J; Szaflik JP
Exp Mol Pathol; 2009 Dec; 87(3):234-8. PubMed ID: 19761764
[TBL] [Abstract][Full Text] [Related]
3. Association of manganese superoxide dismutase gene polymorphism (V16A) with diabetic macular edema in Korean type 2 diabetic patients.
Lee SJ; Choi MG
Metabolism; 2006 Dec; 55(12):1681-8. PubMed ID: 17142144
[TBL] [Abstract][Full Text] [Related]
4. Association between sorbitol dehydrogenase gene polymorphisms and type 2 diabetic retinopathy.
Szaflik JP; Majsterek I; Kowalski M; Rusin P; Sobczuk A; Borucka AI; Szaflik J; Blasiak J
Exp Eye Res; 2008 Apr; 86(4):647-52. PubMed ID: 18289528
[TBL] [Abstract][Full Text] [Related]
5. VEGF -634G>C polymorphism and diabetic retinopathy risk: a meta-analysis.
Qiu M; Xiong W; Liao H; Li F
Gene; 2013 Apr; 518(2):310-5. PubMed ID: 23353010
[TBL] [Abstract][Full Text] [Related]
6. Polymorphism of the manganese superoxide dismutase gene but not of vascular endothelial growth factor gene is a risk factor for diabetic retinopathy.
Kangas-Kontio T; Vavuli S; Kakko SJ; Penna J; Savolainen ER; Savolainen MJ; Liinamaa MJ
Br J Ophthalmol; 2009 Oct; 93(10):1401-6. PubMed ID: 19628492
[TBL] [Abstract][Full Text] [Related]
7. Vitreous and aqueous concentrations of proangiogenic, antiangiogenic factors and other cytokines in diabetic retinopathy patients with macular edema: Implications for structural differences in macular profiles.
Patel JI; Tombran-Tink J; Hykin PG; Gregor ZJ; Cree IA
Exp Eye Res; 2006 May; 82(5):798-806. PubMed ID: 16324700
[TBL] [Abstract][Full Text] [Related]
8. Polymorphism R25P in the gene encoding transforming growth factor-beta (TGF-beta1) is a newly identified risk factor for proliferative diabetic retinopathy.
Beránek M; Kanková K; Benes P; Izakovicová-Hollá L; Znojil V; Hájek D; Vlková E; Vácha J
Am J Med Genet; 2002 May; 109(4):278-83. PubMed ID: 11992481
[TBL] [Abstract][Full Text] [Related]
9. VEGF polymorphisms are associated with severity of diabetic retinopathy.
Churchill AJ; Carter JG; Ramsden C; Turner SJ; Yeung A; Brenchley PE; Ray DW
Invest Ophthalmol Vis Sci; 2008 Aug; 49(8):3611-6. PubMed ID: 18441306
[TBL] [Abstract][Full Text] [Related]
10. Involvement of circulating endothelial progenitor cells and vasculogenic factors in the pathogenesis of diabetic retinopathy.
Lee IG; Chae SL; Kim JC
Eye (Lond); 2006 May; 20(5):546-52. PubMed ID: 15905870
[TBL] [Abstract][Full Text] [Related]
11. [Changes of plasma endothelin-1 and vascular endothelial growth factor in diabetic retinopathy and the clinical application value thereof].
Zhu H; Shi CH
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(40):2837-9. PubMed ID: 18167288
[TBL] [Abstract][Full Text] [Related]
12. Relationship between polymorphisms 804C/A and 252A/G of lymphotoxin-alpha gene and -308G/A of tumor necrosis factor alpha gene and diabetic retinopathy in Japanese patients with type 2 diabetes mellitus.
Yoshioka K; Yoshida T; Takakura Y; Umekawa T; Kogure A; Toda H; Yoshikawa T
Metabolism; 2006 Oct; 55(10):1406-10. PubMed ID: 16979413
[TBL] [Abstract][Full Text] [Related]
13. The relationships between type 2 diabetic retinopathy and VEGF-634G/C and VEGF-460C/T polymorphisms in Han Chinese subjects.
Yuan Y; Wen Z; Guan Y; Sun Y; Yang J; Fan X; Yang X; Liu R
J Diabetes Complications; 2014; 28(6):785-90. PubMed ID: 25217793
[TBL] [Abstract][Full Text] [Related]
14. EDN1 Lys198Asn is associated with diabetic retinopathy in type 2 diabetes.
Li H; Louey JW; Choy KW; Liu DT; Chan WM; Chan YM; Fung NS; Fan BJ; Baum L; Chan JC; Lam DS; Pang CP
Mol Vis; 2008 Sep; 14():1698-704. PubMed ID: 18806884
[TBL] [Abstract][Full Text] [Related]
15. Role of the VEGF 936 C/T polymorphism in diabetic microvascular complications in type 2 diabetic patients.
Kim HW; Ko GJ; Kang YS; Lee MH; Song HK; Kim HK; Cha DR
Nephrology (Carlton); 2009 Oct; 14(7):681-8. PubMed ID: 19796028
[TBL] [Abstract][Full Text] [Related]
16. Toll-like receptor 4 gene polymorphism and early onset of diabetic retinopathy in patients with type 2 diabetes.
Buraczynska M; Baranowicz-Gaszczyk I; Tarach J; Ksiazek A
Hum Immunol; 2009 Feb; 70(2):121-4. PubMed ID: 19135114
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor gene polymorphism prevalence in patients with diabetic macular oedema and its correlation with anti-vascular endothelial growth factor treatment outcomes.
El-Shazly SF; El-Bradey MH; Tameesh MK
Clin Exp Ophthalmol; 2014; 42(4):369-78. PubMed ID: 23927080
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor gene polymorphisms associated with prognosis for patients with colorectal cancer.
Kim JG; Chae YS; Sohn SK; Cho YY; Moon JH; Park JY; Jeon SW; Lee IT; Choi GS; Jun SH
Clin Cancer Res; 2008 Jan; 14(1):62-6. PubMed ID: 18172253
[TBL] [Abstract][Full Text] [Related]
19. Association of VEGF genetic polymorphisms with prostate carcinoma risk and clinical outcome.
Sfar S; Hassen E; Saad H; Mosbah F; Chouchane L
Cytokine; 2006 Jul; 35(1-2):21-8. PubMed ID: 16908180
[TBL] [Abstract][Full Text] [Related]
20. Association between functional haplotypes of vascular endothelial growth factor and renal complications in Henoch-Schönlein purpura.
Rueda B; Perez-Armengol C; Lopez-Lopez S; Garcia-Porrua C; Martín J; Gonzalez-Gay MA
J Rheumatol; 2006 Jan; 33(1):69-73. PubMed ID: 16395752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
